
Please try another search
Investing.com -- Cidara Therapeutics (NASDAQ:CDTX) stock fell 4% in after-hours trading on Monday following the company's announcement of a proposed public offering of common stock. The biotechnology...
SAN DIEGO - Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company with a market capitalization of $580.66 million, announced Monday plans to commence an underwritten public offering of $250...
Cidara Therapeutics (NASDAQ:CDTX), Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced...
Investing.com -- Cidara Therapeutics Inc (NASDAQ:CDTX) stock surged 90.1% following the announcement of positive topline results from its Phase 2b NAVIGATE trial evaluating CD388 for seasonal...
SAN DIEGO - Cidara Therapeutics, Inc. (NASDAQ:CDTX), a $273 million market cap biotechnology company whose stock has surged over 80% in the past year according to InvestingPro data, announced Monday...
Cidara Therapeutics, Inc. (Nasdaq: NASDAQ:CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced positive topline...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review